Le Lézard
Classified in: Health
Subject: SVY

Viral Inactivation Market, 2023 - Market to Grow with a CAGR of 10.9%


DUBLIN, December 14, 2017 /PRNewswire/ --

The "Viral Inactivation Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to Research and Markets' offering.

Research and Markets Logo

Global viral inactivation market to grow with a CAGR of 10.9% over the period of 2017-2023

The study on viral inactivation market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and row for the period of 2015 to 2023.

The report on Viral Inactivation Market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the Global Viral Inactivation Market over the period of 2015 to 2023. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the Global Viral Inactivation Market over the period of 2015 - 2023. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Viral Inactivation Market Overview
3.1 Introduction
3.2 Market Dynamics
3.3 Porter's Five Forces Analysis
3.4 Growth Matrix Analysis
3.5 Competitive Landscape in the Global Viral Inactivation Market

4. Global Viral Inactivation Market by Method 2017 - 2023
4.1 Solvent Detergent Method
4.2 Pasteurization
4.3 Other Methods

5. Global Viral Inactivation Market by Product 2017 - 2023
5.1 Kits and Reagents
5.2 Services
5.3 Viral Inactivation Systems and Accessories

6. Global Viral Inactivation Market by Application 2017 - 2023
6.1 Vaccines and Therapeutics
6.2 Blood and Blood Products
6.3 Cellular and Gene Therapy Products
6.4 Tissues and Tissue Products
6.5 Stem Cell Products

7. Global Viral Inactivation Market by End User 2017 - 2023
7.1 Pharmaceutical and Biotechnology Companies
7.2 Contract Research Organizations
7.3 Academic Research Institutes
7.4 Other End Users

8. Global Viral Inactivation Market by Regions 2017 - 2023

9. Companies Covered

For more information about this report visit https://www.researchandmarkets.com/research/bxvpsq/viral?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


These press releases may also interest you

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...



News published on and distributed by: